Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126642371 | 12664237 | 1 | I | 201604 | 20160811 | 20160818 | 20160818 | EXP | DE-ELI_LILLY_AND_COMPANY-DE201608007034 | ELI LILLY AND CO | 57.00 | YR | M | Y | 80.00000 | KG | 20160818 | CN | DE | DE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126642371 | 12664237 | 1 | PS | CIALIS | TADALAFIL | 1 | Oral | 10 MG, PRN | Y | Y | 21368 | 10 | MG | TABLET | |||||
| 126642371 | 12664237 | 2 | C | SIMVASTATIN. | SIMVASTATIN | 1 | Oral | 20 MG, UNK | 0 | 20 | MG | ||||||||
| 126642371 | 12664237 | 3 | C | LOSARTAN. | LOSARTAN | 1 | Oral | 25 MG, UNK | 0 | 25 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126642371 | 12664237 | 1 | Erectile dysfunction |
| 126642371 | 12664237 | 2 | Coronary artery disease |
| 126642371 | 12664237 | 3 | Coronary artery disease |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126642371 | 12664237 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126642371 | 12664237 | Muscular weakness | Muscular weakness |
| 126642371 | 12664237 | Myalgia | Myalgia |
| 126642371 | 12664237 | Somnolence | Somnolence |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |